Paxalisib (GDC-0084)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed GlioblastomaNCT03522298Kazia Therapeutics LimitedPhase 2Completed2023-03-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.